Why is Biofil Chemicals falling/rising?

As of 02-Jul, Biofil Chemicals & Pharmaceuticals Ltd is currently priced at 46.25, reflecting a slight increase of 0.25 or 0.54%. The stock has recently shown signs of a trend reversal, gaining after three consecutive days of decline. However, it remains below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally weak performance. The stock has underperformed significantly over various time frames, with a 1-year return of -30.71% and a year-to-date decline of -18.86%. Additionally, the company's fundamentals are concerning, with a weak operating profit growth rate of -20.95% CAGR over the last five years and a low return on equity of 4.50%, which suggests low profitability. The recent flat results in net sales and a poor EBIT to interest ratio further contribute to the stock's negative outlook.
In the broader market context, the stock's short-term performance has lagged behind the benchmark, with a 1-week return of -2.82% compared to the Sensex's gain of +0.79%. This underperformance is compounded by a decrease in investor participation, as evidenced by a 10.46% drop in delivery volume against the 5-day average. Despite the stock's recent uptick, the overall sentiment remains bearish due to its long-term underperformance and weak financial fundamentals, which may deter potential investors.